Global Cell Line Development Market Report By Product (Reagents & Media, Equipment, And Accessories & Consumables), Source (Mammalian And Non-Mammalian), By Cell Line (Recombinant, Hybridomas, Hybridomas, And Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, And Research) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11210338

January 2020

Report Formats:

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Description
Table Of Content

As per this study the Global Cell Line Development Market was valued USD XXX MN (by revenue) in 2019 and is anticipated to reach USD XXX MN by 2026 with a CAGR of X.X%.

Cell line development is a process which helps to produce therapeutic drugs through genetic manipulation of organism or cell. It improves the high yield of pharmaceutical products by reducing production cost. Cell line development is also used to produced vaccines, cell culture, and drug discovery. They have application across biopharmaceutical, Research center, and biotechnology sector.

Market Dynamics

Expanding biopharmaceutical industry is expected to drive the demand for cell line development procedure. Rising demand for monoclonal antibodies, cancer therapeutics drugs, and the availability of advanced technologies to produce novel cell lines are again expected to augment market growth. Also, the rising prevalence of chronic diseases needs effective treatment solutions thereby fueling the demand to produce vaccines, biosimilars, therapeutic proteins, and novel drugs over the forecast timeline. Moreover, growing adoption of regenerative medicine, increasing healthcare expenditure and the rise in investments in the biotechnology sector are also some of the major factors contributing to the industry growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of cell line development.

Market Segmentation

The broad cell line development market has been sub-grouped into product, source, cell line, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Product

Reagents & Media
Equipment
Accessories & Consumables

By Source

Mammalian
Non-Mammalian

By Cell Line

Recombinant
Hybridomas
Continuous Cell Line
Primary Cell Line

By Application

Bioproduction
Drug Discovery
Toxicity Testing
Tissue Engineering
Research

Regional Analysis

Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for cell line development in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Europe Cell Line Development Market By Revenue (USD MN)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the cell line development market include American Type Culture Collection, Cytovance Biologics, GE Healthcare, Lonza Group AG, Sartorius Stedim Biotech GmbHCorning Inc., Selexis SA, Sigma-Aldrich Corporation (Merck), Thermo Fisher Scientific Inc., and WuXi AppTec. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Cell Line Development Market
       2.2. Global Cell Line Development Market Snapshot

3 . CELL LINE DEVELOPMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Cell Line Development Market
       3.3. Market Restraints of Cell Line Development Market
       3.4. Opportunities of Cell Line Development Market
       3.5. Trends of Cell Line Development Market
       3.6. Porter’s Five Force Analysis of Cell Line Development Market
       3.7. Cell Line Development Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Source
           3.7.3 Market Attractive Analysis by Cell Line
           3.7.4 Market Attractive Analysis by Application
           3.7.5 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Cell Line Development Value Chain Analysis
       4.2. Cell Line Development Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Cell Line Development Raw Material Manufactures List
           4.2.3. Price Trend of Cell Line Development Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
          4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL LINE DEVELOPMENT MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Cell Line Development Market Analysis by Product
       5.3 Market Analysis of Reagents & Media by Regions
       5.4 Market Analysis of Equipment by Regions
       5.5 Market Analysis of Accessories & Consumables by Regions

6 . GLOBAL CELL LINE DEVELOPMENT MARKET ANALYSIS BY SOURCE
       6.1 Overview by Source
       6.2 Global Cell Line Development Market Analysis by Source
       6.3 Market Analysis of Mammalian by Regions
       6.4 Market Analysis of Non-Mammalian by Regions

7 . GLOBAL CELL LINE DEVELOPMENT MARKET ANALYSIS BY CELL LINE
       7.1 Overview by Cell Line
       7.2 Global Cell Line Development Market Analysis by Cell Line
       7.3 Market Analysis of Recombinant by Regions
       7.4 Market Analysis of Hybridomas by Regions
       7.5 Market Analysis of Continuous Cell Line by Regions
       7.6 Market Analysis of Primary Cell Line by Regions

8 . GLOBAL CELL LINE DEVELOPMENT MARKET ANALYSIS BY APPLICATION
       8.1 Overview by Application
       8.2 Global Cell Line Development Market Analysis by Application
       8.3 Market Analysis of Bioproduction by Regions
       8.4 Market Analysis of Drug Discovery by Regions
       8.5 Market Analysis of Toxicity Testing by Regions
       8.6 Market Analysis of Tissue Engineering by Regions
       8.7 Market Analysis of Research by Regions

9 . GLOBAL CELL LINE DEVELOPMENT MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Cell Line Development Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Cell Line Development Market Estimate by Market Segment
           9.4.3. Europe Cell Line Development Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Cell Line Development Market Estimate by Market Segment
           9.5.3. Asia Pacific Cell Line Development Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Cell Line Development Market Estimate by Market Segment
           9.6.3. Latin America Cell Line Development Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Cell Line Development Market Estimate by Market Segment
           9.7.3. Middle East & Africa Cell Line Development Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa

10 COMPETITIVE LANDSCAPE OF THE CELL LINE DEVELOPMENT COMPANIES
       10.1. Cell Line Development Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 COMPANY PROFILES OF CELL LINE DEVELOPMENT INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. American Type Culture Collection
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Cytovance Biologics
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. GE Healthcare
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Lonza Group AG
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Sartorius Stedim Biotech GmbH
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Corning Inc.
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Selexis SA
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Sigma-Aldrich Corporation (Merck)
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Thermo Fisher Scientific Inc.
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. WuXi AppTec
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Others
           11.13.1. Company Overview
           11.13.2. Financials
           11.13.3. Products
           11.13.4. Recent Developments

12. IMPACT ANALYSIS OF COVID-19 OUTBREAK
12.1. Impact Analysis of Covid-19 Outbreak on the Market
12.1.1. Direct Impact on Production
12.1.2. Supply Chain and Market Disruption
12.1.3. Financial Impact on Firms and Financial Markets
12.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
12.3. Pre V/S Post COVID-19 Market
12.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
12.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

ID:VMR11210338

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

ID:VMR11210338

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

Important: Covid19 pandemic market impact